Keller-Hamilton Brittney, Sloan Ruth, Mehta Toral, Hinton Alice, Tackett Alayna P, Roberts Megan E, Brinkman Marielle C, Wagener Theodore L
Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA.
Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Addiction. 2025 Mar;120(3):503-513. doi: 10.1111/add.16531. Epub 2024 May 27.
To measure nicotine delivery, vaping topography and subjective effects of current generations of disposable, cartridge-based and other types of electronic cigarettes (e-cigarettes) among young adults.
DESIGN, SETTING, PARTICIPANTS: Observational, human laboratory assessment of e-cigarette use in Columbus, Ohio, USA (July 2020 to June 2021). Participants (n = 96, 60.4% female, age mean = 21.7 [standard deviation = 1.7] years, 82.4% white race) were identified via their participation in a cohort study or other convenience sampling and were 18 to 25 years old, vaped ≥4 days/week for ≥4 weeks and used other tobacco products for ≤5 days of past 30 days. Participants completed a pre-vaping questionnaire, vaped their usual brand of e-cigarette ad libitum for 30 min and completed a post-vaping questionnaire.
Outcome variables included pre- and post-vaping measures of plasma nicotine (t = 0 and t = 30, respectively) and craving and withdrawal symptoms, as well as vaping topography (e.g. flow rate and inter-puff interval), pre-vaping expectancies and post-vaping product appeal. Variables used to characterize the sample included demographics, e-cigarette and other tobacco use history, e-cigarette dependence and e-cigarette device characteristics (e.g. device type, flavor and nicotine form).
Participants reported moderate nicotine dependence on average via the E-Cigarette Dependence Scale (mean = 6.9 [standard deviation = 4.0]). Following 30 min of ad libitum vaping, participants achieved substantial plasma nicotine boost (mean = 18.8 [standard deviation = 14.5] ng/mL), corresponding with statistically significant decreases in withdrawal symptoms measured via the Minnesota Nicotine Withdrawal Scale (pre-vaping mean = 9.0 [standard deviation = 5.1], post-vaping mean = 4.3 [standard deviation = 3.9]; P-value <0.0001). Pre-vaping, participants reported moderate vaping expectancies (e.g. mean = 2.5 [standard deviation = 1.0] on a scale from 0 to 4 for smell and taste expectancies); post-vaping, participants reported high satisfaction (mean = 4.6 [standard deviation = 1.2] on a scale from 1 to 7) and moderate reward (mean = 2.9 [standard deviation = 1.2]) and respiratory sensations (mean = 3.7 [standard deviation = 1.6]). Nearly half of participants (47.9%) used disposable e-cigarettes, and most used a mint/menthol or fruit flavored (99.0%) and nicotine salt (98.9%) e-liquid.
Among young adults in the United States, the latest generations of e-cigarettes appear to deliver large quantities of nicotine (similar to cigarettes) and significantly relieve withdrawal symptoms, and they are appealing.
测量当代一次性、烟弹式及其他类型电子烟在年轻成年人中的尼古丁输送量、抽吸特征及主观效应。
设计、地点、参与者:在美国俄亥俄州哥伦布市进行的关于电子烟使用的观察性人体实验室评估(2020年7月至2021年6月)。参与者(n = 96,60.4%为女性,平均年龄 = 21.7岁[标准差 = 1.7],82.4%为白人)通过参与队列研究或其他便利抽样确定,年龄在18至25岁之间,每周抽吸电子烟≥4天,持续≥4周,且在过去30天内使用其他烟草产品≤5天。参与者完成了抽吸前问卷,随意抽吸其常用品牌的电子烟30分钟,然后完成抽吸后问卷。
结果变量包括抽吸前和抽吸后血浆尼古丁测量值(分别为t = 0和t = 30时)、渴望及戒断症状,以及抽吸特征(如流速和抽吸间隔)、抽吸前预期和抽吸后产品吸引力。用于描述样本的变量包括人口统计学特征、电子烟及其他烟草使用史、电子烟依赖程度和电子烟设备特征(如设备类型、口味和尼古丁形态)。
参与者通过电子烟依赖量表报告平均有中度尼古丁依赖(平均值 = 6.9[标准差 = 4.0])。在随意抽吸30分钟后,参与者的血浆尼古丁水平大幅升高(平均值 = 18.8[标准差 = 14.5]ng/mL),这与通过明尼苏达尼古丁戒断量表测量的戒断症状有统计学意义的降低相对应(抽吸前平均值 = 9.0[标准差 = 5.1],抽吸后平均值 = 4.3[标准差 = 3.9];P值<0.0001)。抽吸前,参与者报告有中度的抽吸预期(例如,气味和口味预期在0至4分的量表上平均值 = 2.5[标准差 = 1.0]);抽吸后,参与者报告有高度满意度(在1至7分的量表上平均值 = 4.6[标准差 = 1.2])、中度奖励感(平均值 = 2.9[标准差 = 1.2])和呼吸感觉(平均值 = 3.7[标准差 = 1.6])。近一半的参与者(47.9%)使用一次性电子烟,大多数使用薄荷/薄荷醇或水果口味(99.0%)和尼古丁盐(98.9%)的电子烟液。
在美国的年轻成年人中,最新一代的电子烟似乎能输送大量尼古丁(与香烟类似),并能显著缓解戒断症状,且具有吸引力。